Skip to content

Medical-device intelligence

Boston Biomedica, Inc.: FDA clearances and recalls

Research Boston Biomedica, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

12 clearance records and 0 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Aug 7, 1997 to Nov 24, 2003.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

12 matching records
Device / recordCompany in FDA recordSourceSource date
BOSTON BIOMEDICA, INC. BORRELIA BURGDORFERI IGM AND IGGK032713 · LSRBoston Biomedica, Inc.510(k)Nov 24, 2003FDA decision date
BBI-BIOTECH RESEARCH LABORATORIES B. BURGDORFERI IGM WESTERN BLOT KITK980351 · LSRBoston Biomedica, Inc.510(k)Mar 5, 1999FDA decision date
ACCURUN(TM) 150 HSV IGG POSITIVE CONTROLK974811 · JJXBoston Biomedica, Inc.510(k)Feb 10, 1998FDA decision date
ACCURUN(TM) 130 BORRELIA BURGDORFERI IGG POSITIVE CONTROLK974809 · LSRBoston Biomedica, Inc.510(k)Feb 5, 1998FDA decision date
ACCURUN(TM) 132 BORRELIA BURDORFERI IGM POSITIVE CONTROLK974810 · LSRBoston Biomedica, Inc.510(k)Feb 5, 1998FDA decision date
ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROLK974261 · LJKBoston Biomedica, Inc.510(k)Dec 11, 1997FDA decision date
ACCURUN 140 RUBELLA IGG POSITIVE CONTROLK972986 · MJXBoston Biomedica, Inc.510(k)Oct 8, 1997FDA decision date
ACCURUN 146 CMV IGM POSITIVE CONTROLK972884 · LKQBoston Biomedica, Inc.510(k)Aug 22, 1997FDA decision date
ACCURUN 121 HAV IGM POSITIVE CONTROLK971657 · JJYBoston Biomedica, Inc.510(k)Aug 12, 1997FDA decision date
ACCURUN 117 HBEAG POSITIVE CONTROLK972048 · JJYBoston Biomedica, Inc.510(k)Aug 12, 1997FDA decision date
ACCURUN 120 HAV IGG POSITIVE CONTROLK971406 · JJYBoston Biomedica, Inc.510(k)Aug 7, 1997FDA decision date
ACCURUN 119 ANTI-HEPATITIS B E ANTIGEN (ANTI-HBE) POSITIVE CONTROLK972307 · JJYBoston Biomedica, Inc.510(k)Aug 7, 1997FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗